Associate Director of Genetics Laboratory Florida Cancer Specialists & Research Institute
As precision oncology continues to advance, laboratories are increasingly internalizing next-generation sequencing testing to improve turnaround times, enhance data control, and streamline access to genomic insights. In this session, Dr. Jennifer Gass, PhD, FACMG, and Dr. Jeanine Ruggeri, PhD, ASCP (MLS), MB, will describe the implementation and expansion of an in-house NGS testing service at Florida Cancer Specialists (FCS), the largest independent medical oncology/hematology practice in the United States. They will cover topics such as drivers for bringing NGS testing in-house, assay selection & implementation/integration, and how they leveraged vendor partnerships in this journey. Join us to hear more about these and other key insights and practical considerations for implementing and scaling a precision oncology testing service within a community oncology setting.
